Literature DB >> 11716756

Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.

E M Coccia1, E Stellacci, M Valtieri, B Masella, T Feccia, G Marziali, J Hiscott, U Testa, C Peschle, A Battistini.   

Abstract

Numerous transcription factors allow haematopoietic cells to respond to lineage- and stage-specific cytokines and to act as their effectors. It is increasingly evident that the interferon regulatory factor-1 (IRF-1) transcription factor can selectively regulate different sets of genes depending on the cell type and/or the nature of cellular stimuli, evoking distinct responses in each. In the present study, we investigated mechanisms underlying the differentiation-inducing properties of granulocytic colony-stimulating factor (G-CSF) and whether IRF transcription factors are functionally relevant in myeloid differentiation. Both normal human progenitors and murine 32Dcl3 myeloblasts induced to differentiate along the granulocytic pathway showed an up-regulation of IRF-1 expression. Ectopic expression of IRF-1 did not abrogate the growth factor requirement of 32Dcl3 cells, although a small percentage of cells that survived cytokine deprivation differentiated fully to neutrophils. Moreover, in the presence of G-CSF, granulocytic differentiation of IRF-1-expressing cells was accelerated, as assessed by morphology and expression of specific differentiation markers. Down-modulation of c-Myb protein and direct stimulation of lysozyme promoter activity by IRF-1 were also observed. Conversely, constitutive expression of IRF-2, a repressor of IRF-1 transcriptional activity, completely abrogated the G-CSF-induced neutrophilic maturation. We conclude that IRF-1 exerts a pivotal role in granulocytic differentiation and that its induction by G-CSF represents a limiting step in the early events of differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716756      PMCID: PMC1222228          DOI: 10.1042/0264-6021:3600285

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.

Authors:  L Manzella; R Gualdi; D Perrotti; N C Nicolaides; G Girlando; M A Giuffrida; A Messina; B Calabretta
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

2.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages.

Authors:  T Tamura; T Nagamura-Inoue; Z Shmeltzer; T Kuwata; K Ozato
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

3.  Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2.

Authors:  E M Coccia; N Del Russo; E Stellacci; R Orsatti; E Benedetti; G Marziali; J Hiscott; A Battistini
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

4.  Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells.

Authors:  E M Coccia; N Passini; A Battistini; C Pini; F Sinigaglia; L Rogge
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

5.  C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts.

Authors:  X Wang; E Scott; C L Sawyers; A D Friedman
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

6.  Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.

Authors:  H Nguyen; A Mustafa; J Hiscott; R Lin
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

7.  STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules.

Authors:  E M Coccia; N Del Russo; E Stellacci; U Testa; G Marziali; A Battistini
Journal:  Int Immunol       Date:  1999-07       Impact factor: 4.823

8.  Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).

Authors:  W B Green; M L Slovak; I M Chen; M Pallavicini; J L Hecht; C L Willman
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

Review 9.  The c-Myb oncoprotein.

Authors:  T J Gonda
Journal:  Int J Biochem Cell Biol       Date:  1998-05       Impact factor: 5.085

10.  Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells.

Authors:  M Lohoff; G S Duncan; D Ferrick; H W Mittrücker; S Bischof; S Prechtl; M Röllinghoff; E Schmitt; A Pahl; T W Mak
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  10 in total

1.  IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation.

Authors:  Feifei Chen; Jian Song; Jiehui Di; Qing Zhang; Hui Tian; Junnian Zheng
Journal:  Tumour Biol       Date:  2012-08-14

2.  Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome.

Authors:  Min Guo; Xiaobo Mao; Qingwei Ji; Mingjian Lang; Songnan Li; Yudong Peng; Wei Zhou; Bo Xiong; Qiutang Zeng
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

3.  A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®.

Authors:  Lin Ming Lee; Eleni G Christodoulou; Pavithra Shyamsunder; Bei Jun Chen; Kian Leong Lee; Tsz Kan Fung; Chi Wai Eric So; Gee Chuan Wong; Enrico Petretto; Owen J L Rackham; S Tiong Ong
Journal:  Oncogene       Date:  2022-10-21       Impact factor: 8.756

4.  Gene cloning and expression analysis of IRF1 in half-smooth tongue sole (Cynoglossus semilaevis).

Authors:  Yang Lu; Qilong Wang; Yang Liu; Changwei Shao; Songlin Chen; Zhenxia Sha
Journal:  Mol Biol Rep       Date:  2014-03-01       Impact factor: 2.316

5.  Interferon regulatory factor-2 drives megakaryocytic differentiation.

Authors:  Emilia Stellacci; Ugo Testa; Eleonora Petrucci; Eleonora Benedetti; Roberto Orsatti; Tiziana Feccia; Marit Stafsnes; Eliana M Coccia; Giovanna Marziali; Angela Battistini
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

6.  The NOTCH pathway contributes to cell fate decision in myelopoiesis.

Authors:  Laurence Bugeon; Harriet B Taylor; Fränze Progatzky; Michelle I Lin; Charles D Ellis; Natalie Welsh; Emma Smith; Neil Vargesson; Caroline Gray; Stephen A Renshaw; Timothy J A Chico; Leonard I Zon; Jonathan Lamb; Margaret J Dallman
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

7.  Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.

Authors:  Marco Sgarbanti; Alessandra Borsetti; Nicola Moscufo; Maria C Bellocchi; Barbara Ridolfi; Filomena Nappi; Giulia Marsili; Giovanna Marziali; Eliana M Coccia; Barbara Ensoli; Angela Battistini
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

8.  BCA2/Rabring7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IκBα.

Authors:  Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

9.  Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate.

Authors:  Natalie A Prow; Thiago D C Hirata; Bing Tang; Thibaut Larcher; Pamela Mukhopadhyay; Tiago Lubiana Alves; Thuy T Le; Joy Gardner; Yee Suan Poo; Eri Nakayama; Viviana P Lutzky; Helder I Nakaya; Andreas Suhrbier
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

10.  Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells.

Authors:  Jacopo Albanesi; Nelida Ines Noguera; Cristina Banella; Tommaso Colangelo; Elisabetta De Marinis; Stefano Leone; Orazio Palumbo; Maria Teresa Voso; Paolo Ascenzi; Clara Nervi; Fabrizio Bianchi; Alessandra di Masi
Journal:  Cells       Date:  2020-11-05       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.